Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2026-01-29 @ 8:03 PM
Study NCT ID:
NCT00653250
Status:
COMPLETED
Last Update Posted:
2013-05-21
First Post:
2008-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-12
Start Date Type:
None
Primary Completion Date:
2006-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-03
First Submit QC Date:
None
Study First Post Date:
2008-04-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-05-20
Last Update Post Date:
2013-05-21
Last Update Post Date Type:
ESTIMATED